Emma Murray

Emma Murray is an associate in the firm’s Litigation department. She joined Goodwin in 2023. Emma is a contributor to the firm’s Big Molecule Watch, an award-winning blog that reports real-time analysis and updates on regulatory issues, litigation, legislation, and other news in the developing world of biosimilars.

Emma is a member of the Massachusetts Bar Association and the Boston Bar Association.

While attending law school, Emma served as a primary editor of the Washington University Journal of Law & Policy and was a member of the Intellectual Property Clinic. She was also a summer associate at Goodwin and an intern for the St. Louis City Counselor’s Office.

• Author, “Skinny Labels and Skinnier Prospects: How a Recent Federal Circuit Court Decision on Patent Infringement Places a Well-Established Generic Drug Practice in Jeopardy,” Washington University Journal of Law and Policy, June 2023